Indication
Chronic hepatitis C - genotype 2
Chronic hepatitis C - genotype 2 refers to a persistent infection of the liver lasting longer than six months, specifically caused by genotype 2 strains of the hepatitis C virus (HCV). Read more about Chronic hepatitis C - genotype 2
29 drugs 13 manufacturers
Drugs that treat it
Common Chronic hepatitis C - genotype 2 therapies.
SOVALDI (sofosbuvir)
MODERIBA (ribavirin)
EPCLUSA (sofosbuvir/velpatasvir)
VOSEVI (sofosbuvir/velpatasvir/voxilaprevir)
MAVYRET (glecaprevir/pibrentasvir)
RIBASPHERE (ribavirin)
MODERIBA (ribavirin)
SOFOSBUVIR-VELPATASVIR (sofosbuvir/velpatasvir)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic hepatitis C - genotype 2 refers to a persistent infection of the liver lasting longer than six months, specifically caused by genotype 2 strains of the hepatitis C virus (HCV).
This viral subtype primarily affects hepatocytes, driving progressive hepatic inflammation, necrosis, and subsequent fibrogenesis.
While patients frequently remain asymptomatic for decades, unresolved infection can advance to severe complications, including compensated or decompensated liver cirrhosis, portal hypertension, hepatic failure, and hepatocellular carcinoma.
Identifying genotype 2 via molecular diagnostic testing is essential for confirming chronicity and tailoring therapeutic regimens, as distinct HCV genotypes demonstrate variable susceptibility and responsiveness to different antiviral drug classes.
- cdc.gov
Chronic hepatitis C - genotype 2 refers to a persistent infection of the liver lasting longer than six months, specifically caused by genotype 2 strains of the hepatitis C virus (HCV) This viral subtype primarily affects hepatocytes, driving progressive hepatic inflammation, necrosis, and subsequent fibrogenesis While patients frequently remain asymptomatic for decades, unresolved infection can advance to severe complications, including compensated or decompensated liver cirrhosis, portal hypert...
- aasld.org
This viral subtype primarily affects hepatocytes, driving progressive hepatic inflammation, necrosis, and subsequent fibrogenesis While patients frequently remain asymptomatic for decades, unresolved infection can advance to severe complications, including compensated or decompensated liver cirrhosis, portal hypertension, hepatic failure, and hepatocellular carcinoma
- uw.edu
While patients frequently remain asymptomatic for decades, unresolved infection can advance to severe complications, including compensated or decompensated liver cirrhosis, portal hypertension, hepatic failure, and hepatocellular carcinoma
- healthline.com
Identifying genotype 2 via molecular diagnostic testing is essential for confirming chronicity and tailoring therapeutic regimens, as distinct HCV genotypes demonstrate variable susceptibility and responsiveness to different antiviral drug classes
- mayocliniclabs.com
Identifying genotype 2 via molecular diagnostic testing is essential for confirming chronicity and tailoring therapeutic regimens, as distinct HCV genotypes demonstrate variable susceptibility and responsiveness to different antiviral drug classes
- va.gov
Identifying genotype 2 via molecular diagnostic testing is essential for confirming chronicity and tailoring therapeutic regimens, as distinct HCV genotypes demonstrate variable susceptibility and responsiveness to different antiviral drug classes
Personalize your experience
Follow Chronic hepatitis C - genotype 2 and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.